StephanieJ.(Nahas)Nahas-GeigerMD
Neurology • Philadelphia, PAHeadache
Associate Professor, Neurology, Thomas Jefferson University
Dr. Nahas-Geiger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
900 Walnut St
Ste 200
Philadelphia, PA 19107Phone+1 215-955-2243Fax+1 215-955-2060
Summary
- Dr. Stephanie Nahas is a neurologist with subspecialty certification in headache medicine practicing in Philadelphia, PA. She is affiliated with Thomas Jefferson University Hospitals. She received her medical degree from Rush Medical College in 2001, completed neurology residency in 2005, followed by fellowship in headache medicine, and has been on faculty at Jefferson since January 2017.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Headache Medicine, 2005 - 2007- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Neurology, 2002 - 2005
Rush University Medical CenterInternship, Internal Medicine, 2001 - 2002
Rush Medical College of Rush University Medical CenterClass of 2001
Certifications & Licensure
FL State Medical License 2021 - Present
PA State Medical License 2002 - 2024- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Fellow American Headache Society
- Fellow American Academy of Neurology
Publications & Presentations
PubMed
- 8 citationsAddressing the Crisis of Diagnosis and Management of Migraine in Primary Care: A Summary of the American Headache Society FrontLine Primary Care Advisory BoardMia T. Minen, Matthew S. Robbins, Elizabeth Loder, Stephanie J. Nahas, Jessica Gautreaux
Headache. 2020-05-01 - 7 citationsBiomarkers in Migraine.Brian M Yan, E M Gibson Depoy, Ayesha Ahmad, Stephanie J. Nahas
Neurology India. 2021-03-01 - 19 citationsRisk factors for migraine disease progression: a narrative review for a patient-centered approach.Richard B Lipton, Dawn C Buse, Stephanie J Nahas, Gretchen E Tietjen, Vincent T Martin
Journal of Neurology. 2023-12-01
Press Mentions
Migraine Nasal Spray with Novel Delivery System Gains FDA ApprovalSeptember 20th, 2021- Impel NeuroPharma Gains FDA Approval for First Therapeutic to Deliver DHE to Vascular-Rich Upper Nasal Space for Migraine Treatment Using POD TechnoloSeptember 4th, 2021
- FDA Approves DHE-Based Migraine Treatment TrudhesaSeptember 3rd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
